Comparison of Biphasic Insulin Aspart 30 Versus Insulin Glargine Both in Combination With Metformin and Glimepiride in Subjects With Type 2 Diabetes

NCT00469092 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

480

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes
Diabetes Mellitus, Type 2

Interventions

DRUG: biphasic insulin aspart
DRUG: insulin glargine
DRUG: metformin
DRUG: glimepiride

Sponsor

Novo Nordisk A/S